These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36286274)

  • 21. Impact of Cardio-Ankle Vascular Index on Long-Term Outcome in Patients with Acute Coronary Syndrome.
    Kirigaya J; Iwahashi N; Tahakashi H; Minamimoto Y; Gohbara M; Abe T; Akiyama E; Okada K; Matsuzawa Y; Maejima N; Hibi K; Kosuge M; Ebina T; Tamura K; Kimura K
    J Atheroscler Thromb; 2020 Jul; 27(7):657-668. PubMed ID: 31631100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Synergistic Effect of Lp(a) and GRACE Score on Cardiovascular Risk in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Cohort Study From China.
    Hu C; Liu J; Han H; Sun Y; Cheng Y; Liu Y; Gao A; Zhou Y; Zhang J; Zhao Y
    Front Cardiovasc Med; 2021; 8():637366. PubMed ID: 33681307
    [No Abstract]   [Full Text] [Related]  

  • 23. Adjustment of the GRACE score by HemoglobinA1c enables a more accurate prediction of long-term major adverse cardiac events in acute coronary syndrome without diabetes undergoing percutaneous coronary intervention.
    Liu XJ; Wan ZF; Zhao N; Zhang YP; Mi L; Wang XH; Zhou D; Wu Y; Yuan ZY
    Cardiovasc Diabetol; 2015 Aug; 14():110. PubMed ID: 26285575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Predictive value of GRACE discharge score for long-term out-of-hospital death in acute coronary syndrome after percutaneous coronary intervention].
    Zhao XY; Li JX; Tang XF; Xu JJ; Song Y; Wang HH; Xu LJ; Chen J; Zhang Y; Song L; Gao LJ; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
    Zhonghua Yi Xue Za Zhi; 2018 Feb; 98(7):496-501. PubMed ID: 29495217
    [No Abstract]   [Full Text] [Related]  

  • 25. Prognostic Value of NT-proBNP in Patients With Successful PCI for ACS and Normal Left Ventricular Ejection Fraction.
    Wang JL; Guo CY; Li HW; Zhao XQ; Zhao SM
    Am J Med Sci; 2022 Apr; 363(4):333-341. PubMed ID: 34986361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic Immune-Inflammation Index Predicts Long-Term Outcomes in Patients with Three-Vessel Coronary Disease After Revascularization: Results from a Large Cohort of 3561 Patients.
    Zhao J; Lv H; Yin D; Zhou X; Zhu H; Guo L; Wang J
    J Inflamm Res; 2022; 15():5283-5292. PubMed ID: 36120186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Value of the Leuko-Glycemic Index in Acute Myocardial Infarction Patients with or without Diabetes.
    Qi LY; Liu HX; Cheng LC; Luo Y; Yang SQ; Chen X; Cai L
    Diabetes Metab Syndr Obes; 2022; 15():1725-1736. PubMed ID: 35706475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of the CYP2C19 metabolizer and the GRACE risk score better predicts the long-term major adverse cardiac events in acute coronary syndrome undergoing percutaneous coronary intervention.
    Bai XF; Zhang YP; Zhou J; Wu Y; Li RF; Sun LZ; Ma QQ; Lou BW; Zhai BW; Liu MP; Cheng LL; Tong XN; Yuan ZY
    Thromb Res; 2018 Oct; 170():142-147. PubMed ID: 30193195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive value of combining the level of lipoprotein-associated phospholipase A2 and antithrombin III for acute coronary syndrome risk.
    Lu J; Niu D; Zheng D; Zhang Q; Li W
    Biomed Rep; 2018 Dec; 9(6):517-522. PubMed ID: 30546880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined Value of Red Blood Cell Distribution Width and Global Registry of Acute Coronary Events Risk Score for Predicting Cardiovascular Events in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Zhao N; Mi L; Liu X; Pan S; Xu J; Xia D; Liu Z; Zhang Y; Xiang Y; Yuan Z; Guan G; Wang J
    PLoS One; 2015; 10(10):e0140532. PubMed ID: 26468876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.
    Vernooij LM; van Klei WA; Moons KG; Takada T; van Waes J; Damen JA
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013139. PubMed ID: 34931303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein(a) and the risk of recurrent events in patients with acute myocardial infarction treated by percutaneous coronary intervention.
    Rigattieri S; Cristiano E; Tempestini F; Lo Monaco M; Cava F; Bongiovanni M; Tifi P; Berni A; Volpe M
    Minerva Cardiol Angiol; 2023 Aug; 71(4):406-413. PubMed ID: 36321889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Lipoprotein(a) With Risk of Recurrent Ischemic Events Following Acute Coronary Syndrome: Analysis of the dal-Outcomes Randomized Clinical Trial.
    Schwartz GG; Ballantyne CM; Barter PJ; Kallend D; Leiter LA; Leitersdorf E; McMurray JJV; Nicholls SJ; Olsson AG; Shah PK; Tardif JC; Kittelson J
    JAMA Cardiol; 2018 Feb; 3(2):164-168. PubMed ID: 29071331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Assessment of Scales of Frailty and Physical Performance Improves Prediction of Major Adverse Cardiac Events in Older Adults with Acute Coronary Syndrome.
    Campo G; Maietti E; Tonet E; Biscaglia S; Ariza-Solè A; Pavasini R; Tebaldi M; Cimaglia P; Bugani G; Serenelli M; Ruggiero R; Vitali F; Formiga F; Sanchis J; Galvani M; Minarelli M; Lucchi GR; Ferrari R; Guralnik J; Volpato S
    J Gerontol A Biol Sci Med Sci; 2020 May; 75(6):1113-1119. PubMed ID: 31075167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation of Fibrinogen-to-Albumin Ratio to Severity of Coronary Artery Disease and Long-Term Prognosis in Patients with Non-ST Elevation Acute Coronary Syndrome.
    Li M; Tang C; Luo E; Qin Y; Wang D; Yan G
    Biomed Res Int; 2020; 2020():1860268. PubMed ID: 32879878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic performance of multiple biomarkers in patients with acute coronary syndrome without standard cardiovascular risk factors.
    Wang L; Cong HL; Zhang JX; Li XM; Hu YC; Wang C; Lang JC; Zhou BY; Li TT; Liu CW; Yang H; Ren LB; Qi W; Li WY
    Front Cardiovasc Med; 2022; 9():916085. PubMed ID: 35966532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort.
    Wang P; Yuan D; Zhang C; Zhu P; Jia S; Song Y; Tang X; Xu J; Li T; Zeng G; Zhao X; Yang Y; Xu B; Gao R; Yuan J
    Cardiovasc Diabetol; 2022 Mar; 21(1):46. PubMed ID: 35313877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nutritional Risk Index Improves the GRACE Score Prediction of Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Ma XT; Shao QY; Li QX; Yang ZQ; Han KN; Liang J; Shen H; Liu XL; Zhou YJ; Wang ZJ
    Front Cardiovasc Med; 2021; 8():773200. PubMed ID: 34977188
    [No Abstract]   [Full Text] [Related]  

  • 39. Impact of Lipoprotein(a) concentrations on long-term cardiovascular outcomes in patients undergoing percutaneous coronary intervention: A large cohort study.
    Cui K; Yin D; Zhu C; Yuan S; Wu S; Feng L; Dou K
    Nutr Metab Cardiovasc Dis; 2022 Jul; 32(7):1670-1680. PubMed ID: 35525680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein(a) levels predict adverse vascular events after acute myocardial infarction.
    Mitsuda T; Uemura Y; Ishii H; Takemoto K; Uchikawa T; Koyasu M; Ishikawa S; Miura A; Imai R; Iwamiya S; Ozaki Y; Kato T; Shibata R; Watarai M; Murohara T
    Heart Vessels; 2016 Dec; 31(12):1923-1929. PubMed ID: 26936452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.